baber/WOPTO huggingface dataset:
Patent AU-688064-B2 (AU)
Title: Coilless bus coupler for an on-board power supply
Inventor: ZIERHUT HERMANN
IPC: H04B3/54
Filed: 1995-06-30
Granted: 1998-03-05
Abstract: PCT No. PCT/DE95/00854 Sec. 371 Date Jul. 25, 1997 Sec. 102(e) Date Jul. 25, 1997 PCT Filed Jun. 30, 1995 PCT Pub. No. WO96/02982 PCT Pub. Date Feb. 1, 1996A device for supplying the on-board system voltage in a bus coupler without a repeater, for coupling to an information and power carrying bus of a bus system, in particular for building systems management. The device includes a coupling circuit having a control input connected to a triggering circuit having inputs for a control criterion. The coupling circuit operates as a constant current source at communications frequencies and as a control circuit together with a triggering circuit at lower frequencies, such as those caused by power consumption. The coupling circuit is effectively connected in series with a reservoir capacitor for tapping the on-board system voltage. The series connection is effectively connected to the bus drivers.
Patent AU-623632-B2 (AU)
Title: A solution of carboplatin
Inventor: LEVIUS HAROLD PHILLIP DR
IPC: A61K47/00
Filed: 1989-02-23
Granted: 1992-05-21
Abstract: Carboplatin is conventionally made into extemporaneous injectable solutions by reconstituting a lyophilisate with water or a dextrose or saline solution. This is difficult and dangerous, and the solutions formed are unstable. The invention provides a stable, ready-made, injectable aqueous carboplatin solution made without reconstituting a lyophilisate - thus, from unlyophilised carboplatin. The solution preferably contains from 10 mg/ml to 15 mg/ml carboplatin, advantageously includes a polyol (up to 10% of mannitol), and a preservative, but is salt-free, and has a pH preferably between 5 and 7.
Patent AU-767892-B2 (AU)
Title: New combined preparation for the treatment of neoplasic diseases or of infectious diseases
Inventor: BARTHOLEYNS JACQUES
IPC: A61K35/14
Filed: 1999-03-29
Granted: 2003-11-27
Abstract: The present invention relates to combined preparation containing as active substance the following individual components, in the form of a kit-of-parts:monocyte derived cells, particularly cytotoxic macrophages,chemotherapy or immunotherapy drugs,for the simultaneous, separate or sequential use, for the treatment of cancer or infectious diseases.
Patent AU-610042-B2 (AU)
Title: A dry microbiocidal composition containing an ethylene bis-dithiocarbamate salt
Inventor: PATEL GIRISH K
IPC: A01N47/10
Filed: 1989-04-12
Granted: 1991-05-09
Abstract: A stable dry microbiocidal composition is disclosed which consists of partially anhydrous alkaline salts of ethylene bis-dithiocarbamate and alkaline salts of dimethyldithiocarbamate. This dry composition has a temperature of combustibility over 170 DEG  C. Methods for preparing the composition are also described.
Patent AU-627735-B2 (AU)
Title: Catalysts for selective catalytic reduction denox technology
Inventor: HEGEDUS LOUIS
IPC: B01J21/06
Filed: 1989-06-06
Granted: 1992-09-03
Abstract: Catalysts for the selective catalytic reduction of NOx by ammonia are made from porous formed supports having a certain fraction of the pores with pore diameters larger than 600 Angstrom units. Thus macropores can be introduced in a formed TiO2 support by adding burnout materials or some inorganic oxide prior to forming the titania into the formed support. Alternatively, titania is precipitated onto a porous inorganic oxide such as SiO2, Al2O3, ZrO2, AlPO4, Fe2O3 and B2O3 to form the support. Then conventional DeNOx catalytic metals are added. The support can be made by first impregnating the inorganic oxide particles with titania via a soluble precursor, forming titania and then shaping the coated particles into the desired shape such as a monolith. In a second embodiment, the inorganic oxide particles are first formed into the desired shape and then impregnated with the titania forming material. Barium sulfate can be added to the surface of the porous inorganic oxide to make an improved support.
Patent AU-577816-B2 (AU)
Title: Combustion cylinder for oil burner
Inventor: NAKAMURA KAZUHARU
IPC: F23D3/22
Filed: 1985-02-07
Granted: 1988-10-06
Abstract: A combustion cylinder construction (12) for an oil burner (10) having a wick (22), is disclosed, which is adapted to adjust combustion while preventing the adhesion of soot, moisture and the like on the inner surface of a heat-permeable cylinder (68) to keep it clean during combustion. The combustion cylinder construction includes a first heat-permeable cylinder (34) and a second heat-permeable cylinder (68) supported on the first haat-permeable cylinder, with a gap (70) being defined therebetween which serves to introduce air from the exterior therethrough to the overall inner surface of the second heat-permeable cylinder.
Patent AU-669539-B2 (AU)
Title: Vacuum cleaner
Inventor: DYSON JAMES
IPC: A47L9/16
Filed: 1993-06-24
Granted: 1996-06-13
Abstract: A vacuum cleaner comprising a dirty air inlet (12, 14) communicating with a clean air outlet by means of an airflow path has a cyclone (18) arranged in the airflow path. In use, air flowing along the airflow path from the dirty air inlet (12, 14) to the clean air outlet passes through the cyclone (18). At least one bleed valve (20) is arranged in the wall of the airflow path upstream of the cyclone (18). Preferably, three bleed valves (20) are located in the wall of the airflow path and, more preferably, the bleed valves (20) are substantially identical to one another. Control means (94, 102) may be provided for controlling the amount of air bled through the bleed valve (76) when a single bleed valve is provided.
Patent AU-743019-B2 (AU)
Title: A process for preparing physically drying coatings from aqueous dispersions
Inventor: IRLE CHRISTOPH
IPC: C08F283/01
Filed: 1999-08-17
Granted: 2002-01-17
Abstract: The use of an aqueous dispersion of a polyol component, comprising 20-60 wt.% unsaturated polyester polyol and 40-80 wt.% polyacrylate, and 1-70 wt.% (with respect to total solids) of a blocked aliphatic polyisocyanate component for light-stable, elastic, physically fast-drying coatings in series lacquering of cars is claimed. The use of an aqueous dispersion of (A) a polyol component and (B) a polyisocyanate component for light-stable, elastic, physically fast-drying coatings in series lacquering of cars is claimed. The polyol component comprises 20-60 wt.% polyester component (AI) with 10-60 wt.% units derived from 8-30 carbon (C) aliphatic (un)saturated monocarboxylic acid(s) and 0.4-5 wt.% units derived from 3-8 C  alpha , beta -unsaturated mono- or dicarboxylic acid(s) or anhydride(s) capable of free radical polymerization and 40-80 wt.% polyacrylate component (AII). The polyisocyanate component (B) comprises blocked aliphatic polyisocyanate(s) and is used in an amount of 1-70 wt.% with respect to total solids in the dispersion.
Patent AU-585529-B2 (AU)
Title: Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
Inventor: VAUGHAN JOHN H
IPC: C07K16/00
Filed: 1985-08-02
Granted: 1989-06-22
Abstract: Antigens, immunogens, inocula, antibodies, diagnostic methods and systems relating to Epstein-Barr virus nuclear antigen (EBNA) are disclosed. Each of the compounds, compositions, methods or systems contains a synthetic, random copolymer polypeptide having about 6 to about 40 residues, or an antibody containing site that immunoreacts with such a polypeptide. The polypeptide includes the five amino acid residue sequence -Gly-R1-Gly-R2-Gly-, wherein R1 and R2 are the same or different amino acid residues selected from the group consisting of Ala, Asn, Arg, Gly, Leu, Pro, Ser, and Thr, with the provision that R1 and R2 are not both Gly. The polypeptide contains at least 25 mole percent Gly residues, and when linked to a carrier and introduced in an effective amount into a mammalian host is capable of inducing production of antibodies that immunoreact with EBNA.
Patent AU-637085-B2 (AU)
Title: New transferrin-polycation conjugates
Inventor: BEUG HARTMUT DR
IPC: C12N15/87
Filed: 1990-03-15
Granted: 1993-05-20
Abstract: The invention relates to a system for the transport of nucleic acids into the cell, which takes place by receptor-mediated endocytosis. A complex can be formed with the polyanionic nucleic acid with the aid of a transferrin-polycation conjugate. This complex is bound to the transferrin receptor, of which there is high regulation in growing cells, and is absorbed into the cell. Suitable nucleic acids are those which inhibit specific genes or RNA function, such as antisense oligonucleotides or ribozymes, or the genes coding therefor. The invention further relates to a process for introducing nucleic acids into the cell, to transferrin-polycation/nucleic acid complexes and to pharmaceutical compositions containing these.
Patent AU-618457-B2 (AU)
Title: Gripping device and holder for handling a tubular fuse
Inventor: HEMMER ALOYSIUS GERARDUS MAJEL
IPC: H01H85/54
Filed: 1990-03-21
Granted: 1991-12-19
Abstract: Gripping device (1) for longitudinally fitting and removing a tubular fuse (32) for electrical medium- and high-voltage installations. The gripping device (1) having a sleeve-type cavity (4) for receiving a terminal electrode (25) of the tubular fuse (32). An annular element (26) having an ellipsoidal projection and bent into a V-shape around its short axis being fitted in the cavity (4) for providing a friction coupling to the terminal electrode (25). For displacing the annular element (26) in axial direction of the cavity (4) by hand, a sleeve (29) is slideably latched over the cavity (4) and provided with an edge (30) abutting the annular element (26). For making electrical contact to the terminal electrode (25) of the tubular fuse (32) contact elements (20) are arranged in the cavity (4). A conductor (6) extends from the cavity (4) for detachably connecting the terminal electrode (25) to a contact (39) of a holder (34) for receiving the tubular fuse (32).
Patent AU-541465-B2 (AU)
Title: Frequency sensing device
Inventor: GURRY GEORGE WILLIAM
IPC: H04L27/26
Filed: 1979-10-26
Granted: 1985-01-10
Abstract: A device for sensing the frequency of an alternating electrical input signal. An autocorrelator (AC) at an input to the device generates a signal having a periodic component of frequency equal to four times the frequency of any periodic component in the input signal. The amplitude of non-periodic components is substantially reduced. The autocorrelator (AC) is followed by a series of sixteen frequency dividers (FD) whose outputs are applied to respective comparators (GC). Within each comparator (GC) the signal from a divider is compared with one of sixteen window signals, each representing a predetermined range of periods. Any output from the comparator (GC) is converted to a binary decimal form and is applied to a qualifier circuit (QC). The qualifier circuit only gives an output if at least eleven of the last eighteen signals applied thereto have represented a signal whose period lies within the same one of the predetermined ranges of periods.
Patent AU-623514-B2 (AU)
Title: Synergistic compositions containing propiconazole and tebuconazole
Inventor: VALCKE ALEX RAYMOND ALBERT
IPC: C07D249/08
Filed: 1990-04-19
Granted: 1992-05-14
Abstract: Synergistic antifungal compositions containing tebuconazole (II) <CHEM>  and propiconazole (I) <CHEM> for treating plants or the loci thereof, or for use in wood-preservation or protection of biodegradable materials. Processes for preparing said synergistic antifungal compositions. A product containing tebuconazole and propiconazole as a combination for simultaneous, separate or sequential use. Method of combating fungi on plants comprising the administration thereto of tebuconazole and propiconazole. Method of protecting wood, wood-products and biodegradable materials from fungal attack and destruction.
Patent AU-666240-B2 (AU)
Title: Process for the preparation of maleamic acid
Inventor: BRUN DANIEL
IPC: C07C233/65
Filed: 1994-01-20
Granted: 1996-02-01
Abstract: The subject of the present invention is a process for the preparation of maleamic acid from maleic anhydride and ammonia, characterised in that the maleic anhydride, in a molten form, and gaseous ammonia are brought together under operating conditions such that the contact surface area between the two compounds is optimised.
Patent AU-685704-B2 (AU)
Title: Torque and/or rotational control apparatus
Inventor: HENNESSY DAVID R
IPC: F16D65/847
Filed: 1996-05-28
Granted: 1998-01-22
Abstract: A torque control device in the form of a brake (10) includes a number of pairs of actuators (18) located on either side of a friction disc by spacers (120) having tear-shaped cross-sections. The actuator pads (32) are removable and held by a spring (80) loaded locking pin (70) in a hole (68) of a backing plate (62) for the pads. A notch formed in the pad and backing plate engages a rail (66) extending from the actuator to prevent rotation about the pin. The friction disc includes long an short upright fins (42, 43) equally spaced between the component discs (40, 41). The fins are free of circumferential interconnections to allow air to pass radially in between. This allows heat energy generated during engagement in clutches or brakes to be efficiently transferred. <IMAGE>
Patent AU-778533-B2 (AU)
Title: 5-cyano-2-aminopyrimidine derivatives
Inventor: BATCHELOR MARK JAMES
IPC: A61P35/00
Filed: 2000-06-19
Granted: 2004-12-09
Abstract: Pyrimidines of formula (1) are described wherein Ar is an optionally substituted aromatic or heteroaromatic group; R<1 >is a hydrogen atom or a straight or branched chain alkyl group; R<2 >is a -X<1>-R<3 >group where X<1 >is a direct bond or a linker atom or group, and R<3 >is an optionally substituted aliphatic, cycloaliphatic, heteroaliphatic, heterocycloaliphatic, aromatic or heteroaromatic group; and the salts, solvates, hydrates and N-oxides thereof. The compounds are selective KDR Kinase and/or FGFr Kinase inhibitors and are of use in the prophylaxis and treatment of disease states assoicated with angiogenesis.
Patent AU-679206-B2 (AU)
Title: Novel sidechain-bearing taxanes and intermediates thereof
Inventor: POSS MICHAEL A
IPC: C07D263/06
Filed: 1993-12-15
Granted: 1997-06-26
Abstract: Novel methods for the preparation of sidechain-bearing taxanes, comprising the preparation of an oxazoline compound, coupling the oxazoline compound with a taxane having a hydroxyl group directly bonded at C-13 thereof to form an oxazoline sidechain-bearing taxane, and opening the oxazoline ring of the oxazoline sidechain-bearing taxane so formed. Novel compounds prepared by the methods of the present invention are also provided.
Patent AU-587277-B2 (AU)
Title: Apparatus and method for interfacing a transducer
Inventor: FOREHAND GILBERT HORTON
IPC: H03M1/56
Filed: 1986-09-09
Granted: 1989-08-10
Abstract: An analog-to-digital conversion technique utilizes an oscillator (6) which provides a primary oscillating signal that drives a counter (24) and that generates a derived signal having a frequency less than the primary signal. The derived signal is integrated for use in comparing against the threshold voltage defining the analog signal to be converted. The comparison of the integrated and the threshold signals provides a pulse width modulated signal which is related to the primary signal. The pulse width modulated signal gates the counter for generating a count at the rate established by the primary signal. This output can be communicated to a microcomputer or other device.
Patent AU-747635-B2 (AU)
Title: Death domain containing receptor 5
Inventor: NI JIAN
IPC: A61P25/28
Filed: 1998-03-17
Granted: 2002-05-16
Abstract: The present invention relates to novel Death Domain Containing Receptor-5 (DR5) proteins which are members of the tumor necrosis factor (TNF) receptor family, and have now been shown to bind TRAIL. In particular, isolated nucleic acid molecules are provided encoding the human DR5 proteins. DR5 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying antagonists and antagonists of DR5 activity.
Patent AU-708170-B2 (AU)
Title: Atopy: diagnosis and therapy
Inventor: COOKSON WILLIAM OSMOND CHARLES
IPC: C12Q1/6883
Filed: 1996-08-29
Granted: 1999-07-29
Abstract: PCT No. PCT/GB96/02095 Sec. 371 Date Feb. 25, 1998 Sec. 102(e) Date Feb. 25, 1998 PCT Filed Aug. 29, 1996 PCT Pub. No. WO97/08338 PCT Pub. Date Mar. 6, 1997The invention relates to a method for diagnosing an individual as having atopy or a predisposition thereto. The method involves demonstrating in the individual the presence or absence of either: (i) an unusual variant form of the gene which codes for the beta sub-unit of the high affinity receptor for IgE (Fc epsilon RI beta ), the variant form comprising a variation in exon (7) which encodes a glycine at amino acid residue 237 instead of glutamic acid which appears at residue 237 in individuals without atopy: or (ii) an unusual polymorphic form of the amino acid sequence for Fc epsilon RI beta , the polymorphic form comprising glycine at amino acid residue 237 instead of glutamic acid which appears at residue 237 in individuals without atopy. Materials and other methods relating to the above diagnostic method are also described.
Patent AU-781739-B2 (AU)
Title: Deployment actuation system for intrafallopian contraception
Inventor: LOWE CHRISTIAN
IPC: A61B17/12
Filed: 2000-08-22
Granted: 2005-06-09
Abstract: Contraception methods, systems and devices generally improve the ease, speed and reliability with which a contraceptive device (12) can be deployed transcervically into an ostium of a fallopian tube. The contraceptive device (12) may remain in a small profile configuration while a sheath (14) is withdrawn proximally, and is thereafter expanded to a large profile configuration engaging the surrounding tissues, by manipulating one or more actuators of a proximal handle (30) with a single hand. This leaves the other hand free to manipulate a hysteroscope, minimizing the number of health care professionals required to deploy the contraceptive device (12).
Patent AU-634015-B2 (AU)
Title: Compositions with enhanced penetration
IPC: A61K9/06
Filed: 1991-01-29
Granted: 1993-02-11
Abstract: The invention comprises a two-ply composite laminate for transmembranal administration of an active medicament consisting of   A.) a layer I comprising a component A consisting of a solvent and an active medicament incorporated in a partly cured elastomer, B.) a layer II laminated onto layer I comprising a component B consisting of a solvent and an active medicament e.g. THA (tacrine) incorporated in a macroporous slab with a pore size of 10 to 100  mu m. h
Patent AU-599637-B2 (AU)
Title: Amino acid chelated compositions
Inventor: ASHMEAD HARVEY H
IPC: A61K47/18
Filed: 1987-02-04
Granted: 1990-07-26
Abstract: Amino acid chelates having a ligand to divalent metal mole ratio of at least 2:1 and having a molecular weight of not more than 1500 and preferably not more than 1000 and also having a stability constant of between about 10 and 10 are formulated for delivery to one or more specific tissue sites within a mammal. The ligand utilized in formulating the amino acid chelate is a naturally occuring amino acid or a dipeptide, tripeptide or quadrapeptide thereof. The selection of an appropriate ligand with which to form the chelate provides a product that, when entering the bloodstream of the mammal, either by mean of oral ingestion or injection, has a propensity to migrate to one or more targeted tissue sites within the mammal.
Patent AU-541608-B2 (AU)
Title: Fuel temperature control system
Inventor: NAYLOR JIMMY CAMERON
IPC: F02M31/16
Filed: 1981-10-06
Granted: 1985-01-10
Abstract: A transfer pump (22) draws fuel from a tank (12) and feeds it via a temperature sensor (38) to an injection pump (30) from which approximately 50% of the fuel is returned as surplus, heated fuel. This fuel is proportioned by a valve (40) between a return line (33) to the tank and a bypass line (42) transferring fuel to the inlet of the transfer pump (22). When the fuel is cold, all or most of the surplus fuel is returned to the transfer pump with the valve (40) in the illustrated position. As the fuel warms up, progressively more of the surplus fuel is returned directly to the tank and the transfer pump only utilises fuel drawn from the tank via a feed line (14). When the engine is running, a shutoff valve (20) has the illustrated position and connects the feed line (14) to the inlet of the transfer pump and connects the outlet of the transfer pump, downstream of the temperature sensor (38), to the inlet of the injection pump (30). To shutoff the engine, the valve (20) is operated to a second position in which it starves the injection pump by connecting the inlet of the injection pump to the inlet of the transfer pump and connecting the outlet of the transfer pump, downstream of the temperature sensor, to the line (14) which then is a return line.
Patent AU-605507-B2 (AU)
Title: Indolo-pyrazino-benzodiazepine derivatives
Inventor: WASLEY JAN W F
IPC: C07D487/14
Filed: 1987-09-30
Granted: 1991-01-17
Abstract: The invention relates to 1,3,4,16b-tetrahydro-2H,10H-indolo[2,1-c]pyrazino[1,2-a][1,4]benzodiaz epine derivatives of the formula I,    <IMAGE>  (I)  wherein R1 is hydrogen, lower alkyl, C3-7-alkenyl, C3-7-alkynyl, 3 to 7 ring-membered cycloalkyl, C2-7-alkyl substituted by a substituent selected from hydroxy, amino, N-mono-lower alkyl-amino and N,N-di-lower alkyl-amino; or R1 is lower alkyl substituted by a substituent selected from 3 to 7 ring-membered cycloalkyl, carboxy, lower alkoxycarbonyl, carbamoyl, N-mono-lower alkyl-carbamoyl, N,N-di-lower alkyl-carbamoyl and lower alkanoyl; or R1 is lower alkyl substituted by either phenyl or benzoyl each of said phenyl or benzoyl radicals being unsubstituted or substituted by up to three members selected from lower alkyl, lower alkoxy, lower alkylthio, halogen and trifluoromethyl; R2 and R3 represent hydrogen, lower alkyl, hydroxy, lowr alkoxy, halogen or trifluoromethyl; and R4 represents hydrogen, lower alkyl, hydroxy-lower alkyl, carboxy, lower alkoxycarbonyl, carbamoyl, N-mono- or N,N-di-lower alkyl-carbamoyl, or formyl; salts and 2N-oxides; which are useful as serotonin-2 receptor antagonists.
Patent AU-745497-B2 (AU)
Title: Pesticide screening system
Inventor: BOUTSALIS PETER
IPC: G01N33/50
Filed: 1998-06-02
Granted: 2002-03-21
Abstract: The present invention is in the field of plant cultivation and pesticide screening. In particular, the invention relates to a quick and easy system for testing asexually propagated plants within a presticide screenign program. The invention further relates to a quick-test kit comprising all the elements needed for asexually propagating plants from a certain mother plant and carrying out the desired testing operations.
Patent AU-728810-B2 (AU)
Title: A process
Inventor: NIKOLOPOULOS ANGELO
IPC: C07C227/36
Filed: 1998-06-26
Granted: 2001-01-18
Abstract: Cis/trans Tilidine base with an enhanced content of the trans isomer is prepared by mixing a substantially pure cis Tilidine base with water under acidic conditions, preferably using phosphoric acid, at pH values between 2 to 6. Alternatively the substantially pure cis Tilidine base is mixed with a solvent, especially diisopropylethylamine or dimethylformamide under basic conditions at pH values of from 8 to 14. The reaction mixtures thus formed are heated to yield isomerised cis/trans Tilidine base with an enhanced content of the trans isomer.
Patent AU-633755-B2 (AU)
Title: Process for the preparation of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5'-phosphate
IPC: C07H19/20
Filed: 1991-06-26
Granted: 1993-02-04
Abstract: A process for the preparation of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate (II) from 9-beta-D-arabinofuranosyl-2-fluoroadenine (I) by phosphorylation is described. The reaction is conducted under anhydrous conditions, particularly where (I) is dried extensively in a vaccum. The compound (II) is an antileukemia and antiviral drug.